Feasibility of SBIRT-PN
Feasibility of Screening, Brief Intervention, Referral to Treatment With Peer Navigation (SBIRT-PN) for Underserved HIV+ Adults 50+ in Primary Care Settings.
4 other identifiers
interventional
86
1 country
3
Brief Summary
Substance misuse is a common problem among HIV+ individuals. Research suggests that a Screening, Brief Intervention, and Treatment (SBIRT) model can be effective in reducing substance misuse in the general older adult population; however these findings have not been verified in the more vulnerable HIV+ older adult population. The present study seeks to address the problem of substance misuse in older HIV+ adults by piloting a SBIRT model for older HIV+ adults in a in a primary care setting. Individual reductions in alcohol and drug use can have significant effects on public health and safety when observed over a large population at risk for substance use problems. With wider dissemination statewide, a relatively low-cost intervention such as SBIRT could offer demonstrated benefits in this population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2018
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 15, 2017
CompletedFirst Posted
Study publicly available on registry
February 17, 2017
CompletedStudy Start
First participant enrolled
February 12, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2022
CompletedResults Posted
Study results publicly available
September 11, 2023
CompletedSeptember 11, 2023
September 1, 2023
3 years
February 15, 2017
March 20, 2023
September 7, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Number of Participants Ranking Intervention as Acceptable
To examine ratings of acceptability, the investigators will use the overall acceptability score and percentage of acceptability. Overall acceptability will be assessed by summing ratings from the 10-item questionnaire to provide a total intervention acceptability score for the intervention, such that acceptability scores for the intervention could range from 10 (low acceptability) to 50 (high acceptability). The intervention will be considered to have acceptability if 80% of the participants rank the intervention as acceptable (i.e., 4 or higher) on 80% or more of the scale items. The investigators will then examine each question of the Acceptability Questionnaire separately to determine strengths and weaknesses of the intervention.
30 Days
Secondary Outcomes (3)
Number of Participants Who Obtained Formal Substance Use Treatment
6 Months
Number of Participants Who Used Different Types of Substances (Self-Reported)
6 Months
Number of Participants Who Used Different Types of Substances (Biologically Confirmed Via Urinalysis)
6 Months
Study Arms (2)
SBIRT Intervention
EXPERIMENTALThe interventionist will discuss substance use and misuse, HIV, and the interaction of aging and substance use; will give the patient feedback on their NM-ASSIST score and assess the patient's readiness to change based on Prochaska's stages of change; motivational interviewing techniques to identify the patients' most salient reasons for addressing substance use issues. Identifying and prioritizing need; problem-solving techniques to help patients identify which services may best help them work towards their goals; will use a referral resource guide to provide the contact information of agency representatives and help the patient formulate a plan for follow-up.
Treatment as Usual
NO INTERVENTIONParticipants in the enhanced care treatment as usual group will receive the same illustrated handout depicting their substance use screening score and the same referral resource guide provided to those in the control group. These will be provided with only a quick introduction by the research assistant to minimize intervention elements in the control condition and to resemble the notification and referral strategy that would be standard care.
Interventions
The interventionist will discuss substance use and misuse and the influence of substance use on self care.
The interventionist will give the patient feedback on their ASSIST score and assess the patient's readiness to change based on Prochaska's stages of change.
The interventionist will use motivational interviewing techniques to identify the patients' most salient reasons for addressing substance use issues.
The interventionist will use problem-solving techniques to help patients identify which services may best help them work towards their goals. Services will include (but are not limited to) emergency crisis services, counseling to deal with substance use, referral to local self-help groups (Alcoholics Anonymous, Narcotics Anonymous, etc.), legal assistance, faith-based counseling, mental health counseling or inpatient substance use treatment.
The interventionist will use a referral resource guide to provide the contact information of agency representatives and help the patient formulate a plan for follow-up.
Eligibility Criteria
You may qualify if:
- Receiving care at an Infectious disease Medical Clinic
- HIV-positive (seropositive confirmed by medical records)
- have a substance misuse screening score indicating moderate or high risk.
You may not qualify if:
- lack fluency in English
- are unwilling to provide information for follow-up
- plan to leave the area within 6 months
- already have a referral to treatment from another provider
- unable to provide informed consent due to cognitive impairment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
University of Florida
Gainesville, Florida, 32611, United States
CAN Community Health
Jacksonville, Florida, 32207, United States
Department of Health in Columbia County",
Lake City, Florida, 32055, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
In March 2020, the COVID-19 pandemic made in-person assessments as described in Phase I (SBIRT-PN \& TAU), particularly involving vulnerable populations such as PLWH and older adults, impossible. Recommendations for social distancing/self-isolation remained in place for extended periods of time. Data was needed regarding the impact of the pandemic, both physically and emotionally, on PLWH. We gathered this data within a specialized HIV care setting in order to optimize health outcomes (Phase II).
Results Point of Contact
- Title
- Katie Kloss
- Organization
- Florida State University
Study Officials
- PRINCIPAL INVESTIGATOR
Nicole Ennis, PHD
Florida State University
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 15, 2017
First Posted
February 17, 2017
Study Start
February 12, 2018
Primary Completion
February 28, 2021
Study Completion
March 31, 2022
Last Updated
September 11, 2023
Results First Posted
September 11, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share